Literature DB >> 8642848

Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL).

S Kondo1, T Kotani, K Tamura, Y Aratake, H Uno, H Tsubouchi, S Inoue, Y Niho, S Ohtaki.   

Abstract

The association of CD26/dipeptidyl peptidase IV (DPPIV) and human T lymphotropic virus type I (HTLV-I) was studied by two approaches. First, we examined the expression of CD26 in peripheral blood mononuclear cells (PBMC) from the patients with adult T cell leukemia/lymphoma (ATLL), an HTLV-I-related malignancy. The expression of CD26 on the surface of PBMC was decreased in all 20 patients with ATLL compared with those from normal individuals (P < 0.01) and the expression of the CD26 gene transcript was not detectable in seven out of eight patients with ATLL. Then we compared the quantity of viral DNA in CD26-negative (CD26-) and CD26-positive (CD26+) cells obtained from 17 HTLV-I healthy carries by using a polymerase chain reaction method. The CD26-cells had a higher copy number of viral DNA than CD26+ cells. These findings indicate that HTLV-I has in vivo tropism to CD26- cells, suggesting that some phenotypes of ATLL cells reflect the in vivo cellular tropism of HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642848     DOI: 10.1016/0145-2126(95)00159-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma.

Authors:  Haipeng Shao; Constance M Yuan; Liqiang Xi; Mark Raffeld; John C Morris; John E Janik; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

2.  Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.

Authors:  Tomohiro Tsuji; Kazuyuki Sugahara; Kazuto Tsuruda; Akiko Uemura; Hitomi Harasawa; Hiroo Hasegawa; Yukio Hamaguchi; Masao Tomonaga; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

3.  Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.

Authors:  B Bauvois; I De Meester; J Dumont; D Rouillard; H X Zhao; E Bosmans
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

Review 4.  Ectopeptidases in pathophysiology.

Authors:  C Antczak; I De Meester; B Bauvois
Journal:  Bioessays       Date:  2001-03       Impact factor: 4.345

5.  DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.

Authors:  Peir-In Liang; Bi-Wen Yeh; Wei-Ming Li; Ti-Chun Chan; I-Wei Chang; Chun-Nung Huang; Ching-Chia Li; Hung-Lung Ke; Hsin-Chih Yeh; Wen-Jeng Wu; Chien-Feng Li
Journal:  Oncotarget       Date:  2017-01-10

Review 6.  Clonal Selection and Evolution of HTLV-1-Infected Cells Driven by Genetic and Epigenetic Alteration.

Authors:  Makoto Yamagishi; Yutaka Suzuki; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.